Renal Protective Effect in Hypertensive Patients : The High Doses of Angiotensin II Receptor Blocker (HARB) Study

• OHISHI Mitsuru

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

• TAKAGI Takashi

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

• ITO Norihisa

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

• TATARA Yuji

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

• HAYASHI Norihiro

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

• SHIOTA Atsushi

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

• IWAMOTO Yoshihiro

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

• KATSUYA Tomohiro

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

• RAKUGI Hiromi

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

• OGIHARA Toshio

  Department of Geriatric Medicine, Osaka University Graduate School of Medicine

Journal

• Hypertens Res

  Hypertens Res 30 (12), 1187-1192, 2007-12-01

Keywords

• valsartan
• high dosage
• changeover
• Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)
• urinary protein excretion

Details

• CRID: 1570572700644117632
• NII Article ID: 10021260461
• NII Book ID: AA10847079
• ISSN: 09169636
• Web Site: https://search.jamas.or.jp/link/ui/2008172864
• Text Lang: en
• Data Source:
  • CiNii Articles